UCB (Euronext Brussels: UCB) announced it has entered into a definitive agreement to acquire Neurona Therapeutics, a clinical-stage biotherapeutics company ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE